Cannabis Market Heating Up As Consumer Demand Rises Along With Revenue Generating Opportunity
Palm Beach, FL – (September 27, 2018) – The cannabis market continues to emerge as a powerhouse, realizing extreme positive market volume as well as high rates of investment from multiple interests while momentum continues to build on a seemingly daily basis. Already a multi-billion-dollar space, analysts are not forecasting the exponential growth to slow anytime soon, with a forecast from Grand View Research projecting it to grow at a CAGR of 34.6% through 2025. Some of the trends and developments in the industry include national and international expansion, brand growth, cannabis as healthcare treatment and innovative product development. With this in mind, many are paying close attention to the wide variety of opportunities in different avenues throughout the marijuana industry. With mainstream consumer good players getting involved in various aspects, there are a number of different ways a growing number of companies are quickly getting involved in this burgeoning industry. Producers in Canada and several U.S. states with legalized recreational use are focusing their marketing strategies on a wide variety of consumers for hopes of generating huge revenue potentials. Active cannabis companies in the markets this week include Earth Science Tech, Inc. (OTC:ETST), Tilary Inc. (NASDAQ:TLRY), The Supreme Cannabis Company Inc. (TSX-V:FIRE.V)(OTCQX:SPRWF), Canopy Growth Corporation (NYSE:CGC)(TSX:WEED.TO), India Globalization Capital, Inc. (NYSE:IGC).
Earth Science Tech, Inc. (OTCQB: ETST) BREAKING NEWS: Earth Science Tech , an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, has received updated coverage from SeeThruEquity, which recognizes the Company’s sales growth, recent activity, and market potential. SeeThruEquity also set a price target of $3.60 on shares of ETST.
“We are excited to be covered by a well-respected Wall Street equity firm and are pleased it has taken notice of our recent financial results, recent accomplishments, and positive outlook. This coverage by SeeThruEquity validates the passion and expectations that we at ETST have for the Earth Science brand and our mission to become a leading biotech player,” stated Nickolas S. Tabraue, president, director and chairman of ETST. View the full SeeThruEquity report here: view report.
Report Highlights Include:
• 1Q19 revenues grow by 64.8% to $166,891 – ETST reported sharp growth in its FY1Q19 (ended June 20, 2018), with revenues in-creasing to $166,891 versus $101,275 in the year-ago period. Revenue growth is attributed to execution in the company’s line of CBD nutraceuticals and supplements, which provide a revenue stream for ETST as it seeks to develop its medical device and pharmaceutical business lines.
• Positive outlook – Revenues are expected to increase throughout the fiscal year as the company meets demand from expanded retail distribution of its products, supported by pre-sales and a recent replenishment of product which should enable conversion to revenue. read article
• Deal with As Seen On TV likely to raise awareness – On the direct to consumer front, the company has engaged As Seen On TV to develop a direct response TV and web campaign over the next twelve months, which should provide further demand and an increase in awareness for high-grade CBD oil. read article Read this and more news for ETST at https://financialnewsmedia.com/news-etst
Other recent developments in the cannabis industry include:
The Supreme Cannabis Company Inc. (TSX-V:FIRE.V)(OTCQX:SPRWF) recently announced its 7Acres subsidiary has entered into a supply agreement with Tilray Inc. (NASDAQ: TLRY) subsidiary Tilray Canada. Under the 12-month agreement starting Oct. 1, which is estimated to have a value of C$12 million ($9.3 million), 7Acres will provide dried cannabis to Tilray Canada to be used primarily to support medical cannabis patients in Canada. “We are happy to provide 7ACRES premium products alongside Tilray’s well-regarded and existing lineup to support medical patients around the world,” said Supreme Cannabis Chief Executive John Fowler. Supreme Cannabis shares have rallied 37% over the past three months, while the Horizons Marijuana Life Sciences Index ETF has climbed 31% and the S&P 500 has gained 7.1%.
Tilary Inc. (NASDAQ:TLRY) recently announced it has successfully exported medical cannabis from Canada to Australia to distribute to critically ill children. Tilray will distribute its CBD 100 product to three hospitals in the state of Victoria via its wholly-owned subsidiary Tilray Australia New Zealand Pty Ltd. The products are being supplied to Royal Children’s Hospital, Monash Children’s Hospital and Austin Health with support from the Government of Victoria’s Department of Health and Human Services, Victoria (DHHS), where they will be distributed to children suffering from intractable epilepsy. Tilray first announced that the company successfully exported medical cannabis products to Victoria in March 2017. The products were distributed to 29 critically ill children through a compassionate access scheme designed to fast-track medical cannabis access for pediatric patients in need. According to the government, these 29 patients became the first in Victoria to legally access medical cannabis.
Canopy Growth Corporation (NYSE:CGC)(TSX:WEED.TO) earlier this week announced that at the Company’s annual general and special meeting of shareholders held on September 26, 2018 (the “Meeting”), shareholders approved the previously-announced $5B CAD ( $4B USD ) private placement of 104,500,000 common shares and 139,745,453 common share purchase warrants of the Company to CBG Holdings LLC (“CBG”), an affiliate of Constellation Brands, Inc. (the “Transaction”). Of the approximately 40.87% of common shares represented at the Meeting, in person or by proxy, approximately 95.41% were voted in favour of the resolution approving the Transaction in accordance with the minority approval requirements under Multilateral Instrument 61-101 and the requirements of the Toronto Stock Exchange based on proxies received by the management appointees. Details of the voting results will be filed under the Company’s profile at www.sedar.com. Subject to the satisfaction or waiver of all of the conditions to the Transaction, including the receipt of regulatory approval under the Investment Canada Act, the Transaction is expected to be completed on or before October 31, 2018.
India Globalization Capital, Inc. (NYSE American:IGC) announced this week that it has executed a distribution and partnership agreement for several products including a sugar free, energy drink called ‘Nitro G’. IGC will pay 797,000 shares of restricted, unregistered, common stock, for a 10-year agreement, with an option for multiple 5-year extensions, for the rights to market the products in the U.S., Canada, Mexico and South America and exclusive global rights to all developed CBD-infused products. IGC plans to create a branded, hemp/CBD-infused version of the formulation that addresses market demand for energy drinks with the inclusion of healthy properties derived from hemp including CBD.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press releases issued by Earth Science Tech, Inc. by the company. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact email: email@example.com – +1(561)325-8757